Biotage AB (publ) (BITGF)
USD 11.5
(31.13%)
USD 11.5
(31.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 488.98 Million USD | 118.91% |
| 2022 | 223.37 Million USD | 1.85% |
| 2021 | 219.31 Million USD | 25.57% |
| 2020 | 174.66 Million USD | 22.41% |
| 2019 | 142.68 Million USD | 26.1% |
| 2018 | 113.15 Million USD | 22.35% |
| 2017 | 92.48 Million USD | 20.85% |
| 2016 | 76.52 Million USD | -3.54% |
| 2015 | 79.33 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 4.86 Billion USD | 969.58% |
| 2024 Q2 | 454.85 Million USD | -5.38% |
| 2024 Q1 | 480.72 Million USD | -1.22% |
| 2023 FY | 486.68 Million USD | 117.88% |
| 2023 Q3 | 456.09 Million USD | -1.21% |
| 2023 Q2 | 461.68 Million USD | 103.82% |
| 2023 Q4 | 486.68 Million USD | 6.71% |
| 2023 Q1 | 226.51 Million USD | 1.41% |
| 2022 Q2 | 210.18 Million USD | -3.74% |
| 2022 FY | 223.37 Million USD | 1.85% |
| 2022 Q4 | 223.37 Million USD | 7.99% |
| 2022 Q3 | 206.84 Million USD | -1.59% |
| 2022 Q1 | 218.34 Million USD | -0.44% |
| 2021 Q1 | 180.78 Million USD | 0.0% |
| 2021 Q4 | 219.31 Million USD | 28.23% |
| 2021 Q3 | 171.04 Million USD | 3.77% |
| 2021 Q2 | 164.82 Million USD | -8.83% |
| 2021 FY | 219.31 Million USD | 25.57% |
| 2020 FY | 174.66 Million USD | 22.41% |
| 2019 FY | 142.68 Million USD | 26.1% |
| 2018 FY | 113.15 Million USD | 22.35% |
| 2017 FY | 92.48 Million USD | 20.85% |
| 2016 FY | 76.52 Million USD | -3.54% |
| 2015 FY | 79.33 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -26503.516% |
| Ansell Limited | 3.23 Billion USD | 84.892% |
| Ansell Limited | 3.24 Billion USD | 84.92% |
| BG Medicine, Inc. | - USD | -Infinity% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -162699.749% |
| Psykey, Inc. | 1.72 Million USD | -28208.435% |
| ConvaTec Group Plc | 3.7 Billion USD | 86.814% |
| ConvaTec Group Plc | 3.71 Billion USD | 86.833% |
| Encision Inc. | 3.81 Million USD | -12731.935% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -74911.94% |
| LifePoint, Inc. | 8.8 Million USD | -5450.904% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -2964.606% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -54535.596% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -8808.449% |
| Reflect Scientific, Inc. | 2.66 Million USD | -18221.707% |
| SmileDirectClub, Inc. | 597.06 Million USD | 18.101% |
| Sector 10, Inc. | 1000.00 USD | -48898758.3% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 89.697% |
| SheerVision, Inc. | 837.56 Thousand USD | -58282.165% |
| United Health Products, Inc. | 284.64 Thousand USD | -171690.131% |
| Vasamed, Inc. | 1.6 Million USD | -30457.146% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -219007.411% |
| Yubo International Biotech Limited | 2.34 Million USD | -20720.863% |